Skip to navigation Skip to content

Chronic thromboembolic pulmonary hypertension (CTEPH) Program in Pharmaceutical Benefits Scheme (PBS) 012-18051110



This document outlines details of PBS-subsidised riociguat for patients with chronic thromboembolic pulmonary hypertension (CTEPH).

For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.

Chronic thromboembolic pulmonary hypertension (CTEPH) quick reference

Restrictions

Authority level and section

PA assessment

Processing system

Prescriber type

Prescriber self-serve

Initial

PB192 form

Written

Electronic

S100:

riociguat

No

OPA

Must be treated in a:

  • centre with expertise in the management of CTEPH

Yes

Titrating

Telephone

Electronic

S100:

riociguat

No

OPA

Must be treated in a:

  • centre with expertise in the management of CTEPH

Yes

Continuing

Telephone

Electronic

S100:

riociguat

No

OPA

Must be treated in a:

  • centre with expertise in the management of CTEPH

 

Yes

Balance of supply

Telephone

Electronic

S100:

riociguat

No

OPA

Must be treated in a:

  • centre with expertise in the management of CTEPH

 

Yes